About Bionic Vision Technologies
Bionic Vision Technologies is a company based in Carlton (Australia) founded in 2015. Bionic Vision Technologies has raised $18 million across 1 funding round from investors including China Huarong Asset Management. Bionic Vision Technologies offers products and services including Bionic Eye System. Bionic Vision Technologies operates in a competitive market with competitors including NovaVision, Sight Science, Amblyotech, Ooyby and Envision Solutions, among others.
- Headquarter Carlton, Australia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$18 M (USD)
in 1 rounds
-
Latest Funding Round
$18 M (USD), Series A
Apr 03, 2017
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bionic Vision Technologies
Bionic Vision Technologies offers a comprehensive portfolio of products and services, including Bionic Eye System.
Delivers visual data to brain for enhanced awareness in blind users.
People of Bionic Vision Technologies
Unlock access to complete
Unlock access to complete
Funding Insights of Bionic Vision Technologies
Bionic Vision Technologies has successfully raised a total of $18M through 1 strategic funding round. The most recent funding activity was a Series A round of $18 million completed in April 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bionic Vision Technologies
Bionic Vision Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include China Huarong Asset Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Asset management services are provided by China Huarong in China.
|
Locked | Locked | Locked |
Investor details for Bionic Vision Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bionic Vision Technologies
Investment portfolio details for Bionic Vision Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bionic Vision Technologies
Detailed financials for Bionic Vision Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bionic Vision Technologies Comparisons
Peer comparison for Bionic Vision Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bionic Vision Technologies
Bionic Vision Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NovaVision, Sight Science, Amblyotech, Ooyby and Envision Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive devices are developed for vision restoration in stroke survivors.
|
|
| Locked | Locked | Locked |
Visual rehabilitation for brain-injured patients with field loss is provided.
|
|
| Locked | Locked | Locked |
An app-based treatment for Amblyopia is provided through visual games.
|
|
| Locked | Locked | Locked |
Smart devices are provided for vision rehabilitation and training.
|
|
| Locked | Locked | Locked |
Delivers comprehensive computer-based therapies for vision restoration.
|
Detailed competitors of Bionic Vision Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bionic Vision Technologies
Complete news archive for Bionic Vision Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bionic Vision Technologies
Bionic Vision Technologies was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Bionic Vision Technologies is headquartered in Carlton, Australia. It is registered at Carlton, Victoria, Australia.
Ash Attia is the current CEO of Bionic Vision Technologies.
Bionic Vision Technologies is a funded company, having raised a total of $18M across 1 funding round to date.
Bionic Vision Technologies (BVT) is a privately held Australian company developing visual prostheses to restore vision to the blind. BVT is developing suprachoroidal positioned retinal prostheses for restoring vision to the blind and the potential to slow the progression of retinal degeneration. BVT products are based on intellectual property generated by Bionic Vision Australia; a national consortium that was supported by the Australian Research Council through its Special Research Initiative in Bionic Vision Science and Technology. BVTs shareholders include State Path Capital Limited, BVI, UOM Commercial Ltd, NewSouth Innovations, Bionics Institute, Centre for Eye Research Australia, NICTA IPR, The Royal Victorian Eye Ear Hospital, Western Sydney University, and the Australian College of Optometry. The BVT product pipeline consists of two generations of devices which aim to increase mobility and independence of patients and give increasing visual acuity. The devices operate by electrically stimulating the remaining retinal cells in patients with retinal degeneration.
Bionic Vision Technologies's top competitors include Sight Science, NovaVision and Ooyby.
Bionic Vision Technologies offers Bionic Eye System.
Bionic Vision Technologies has 1 investor. Key investors include China Huarong Asset Management.